FDA Import Refusal 1FX-2315637-6/10002/6 — The Madras Pharmaceuticals
The FDA refused shipment 1FX-2315637-6/10002/6 from The Madras Pharmaceuticals (India) on Sep 10, 2026. The refused product falls under Drugs and Biologics — MEBEVERINE HCL (RELAXANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 10, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 65QCA44 MEBEVERINE HCL (RELAXANT)
- Charges
- 75